Ladenburg Thalmann cut shares of CONMED (NASDAQ:CNMD) from a buy rating to a neutral rating in a research note issued to investors on Friday,TheFlyOnTheWall.com reports. The firm currently has $55.00 price target on the stock. A number of other firms have also recently